|
|
|
Insider
Information: |
Kelly James Patrick |
Relationship: |
EVP, CFO and Treasurer |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
200,154 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$961,545 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
200,154 |
|
|
Total
Value |
$961,545 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
-19.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vanda Pharmaceuticals Inc. |
VNDA |
EVP & Chief Financial ... |
2020-03-03 |
186,869 |
2011-08-29 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
EVP, CFO and Treasurer |
2024-03-10 |
13,285 |
2022-08-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
208,066 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2018-03-01 |
4 |
S |
$18.72 |
$159,712 |
D/D |
(8,532) |
199,534 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2019-01-02 |
4 |
S |
$26.31 |
$117,579 |
D/D |
(4,442) |
195,092 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2019-01-03 |
4 |
S |
$26.09 |
$42,232 |
D/D |
(1,619) |
193,473 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
223,473 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2019-03-01 |
4 |
S |
$20.15 |
$100,271 |
D/D |
(4,976) |
218,497 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2019-03-04 |
4 |
S |
$19.88 |
$173,961 |
D/D |
(8,751) |
209,746 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2020-01-02 |
4 |
S |
$15.94 |
$64,086 |
D/D |
(4,020) |
205,726 |
0 |
% |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2020-03-02 |
4 |
S |
$10.19 |
$132,087 |
D/D |
(12,968) |
192,758 |
0 |
% |
|
VNDA |
Vanda Pharmaceuticals Inc... |
EVP & Chief Financial Officer |
|
2020-03-03 |
4 |
S |
$10.76 |
$63,359 |
D/D |
(5,889) |
186,869 |
0 |
% |
|
35 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|